Anti-Mouse TNFα [Clone TN3-19.12] – Purified in vivo PLATINUM™ Functional Grade

Anti-Mouse TNFα [Clone TN3-19.12] – Purified in vivo PLATINUM™ Functional Grade

Product No.: T703

- -
- -
Clone
TN3-19.12
Target
TNF-α
Formats AvailableView All
Product Type
Monoclonal Antibody
Alternate Names
TNF-alpha, TNFSF2, Cachectin, Differentiation-Inducing Factor (DIF), Necrosin, Cytotoxin
Isotype
IgG
Applications
in vivo
,
IP
,
N
,
WB

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Mouse
Host Species
Armenian Hamster
Recommended Dilution Buffer
Immunogen
Purified Recombinant Mouse TNF-α
Product Concentration
2.0 mg/ml
Endotoxin Level
<0.5 EU/mg as determined by the LAL method
Purity
≥98% monomer by analytical SEC
>95% by SDS Page
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Product Preparation
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Pathogen Testing
To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco’s Purified Functional PLATINUM™ antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile.
Storage and Handling
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day 2-8°C
Applications and Recommended Usage?
Quality Tested by Leinco
WB
Additional Applications Reported In Literature ?
IP
Additional Reported Applications For Relevant Conjugates ?
N
For specific conjugates of this clone, review literature for suggested application details.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
Clone TN3-19.12 recognizes mouse TNFα.
Background
TNF-α is a 17.5 kD protein that mediates inflammation and immunity caused by the invasion of viruses, bacteria, and parasites by initiating a cascade of cytokines that increase vascular permeability, thus bringing macrophages and neutrophils to the site of infection. TNF-α secreted by the macrophage causes the blood to clot which provides containment of the infection. TNF-α binding to surface receptors brings about various biologic activities that include cytolysis and cytostasis of many tumor cell lines In vitro, hemorraghic necrosis of tumors In vivo, increased fibroblast proliferation, and enhanced chemotaxis and phagocytosis in neutrophils.
Antigen Distribution
TNF-α is secreted by macrophages, monocytes, neutrophils, T cells, B cells, NK cells, LAK cells.
Ligand/Receptor
TNFRSF1A (TNF-R1, CD120a, TNFR-p60 Type β, p55); TNFRSF1B (TNF-R2, CD120b, TNFR-p80 Type A, p75)
NCBI Gene Bank ID

Leinco Antibody Advisor

Powered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments.

Clone TN3-19.12 is primarily used in in vivo mouse studies to neutralize endogenous TNF-alpha (and to some extent TNF-beta) in order to examine the physiological and pathological roles of tumor necrosis factor during immune responses, inflammation, and disease models.

Essential Context and Supporting Details:

  • Neutralization of TNF Activity:
    TN3-19.12 is a monoclonal antibody generated against mouse TNF-alpha and shown to cross-react with TNF-beta. When administered to mice, it binds to and neutralizes circulating TNF, effectively blocking its biological activity in vivo.

  • Typical Experimental Use:
    The antibody is injected into mice (for example, intraperitoneally) prior to or during models of inflammatory challenge—such as administration of LPS (lipopolysaccharide)—to analyze the effects of TNF blockade. In Sheehan et al., injection of TN3-19.12 before LPS challenge:

    • Prevented detection of TNF in the blood.
    • Protected mice from the lethal effects of endotoxin shock.
    • Established that observed physiological effects were due to neutralization of mouse TNF.
  • Functional Grade Use:
    The antibody is supplied as a low-endotoxin, in vivo grade monoclonal, making it suitable and safe for administration in live animals to study mechanistic roles of TNF in disease or immunological models.

  • Applications:

    • Acute and chronic inflammation models (e.g., sepsis, autoimmunity, infection).
    • Functional studies of TNF in immunity or disease.
    • Survival studies in TNF-mediated shock (as a positive control for TNF blockade).

Specifics:

  • The antibody completely inhibits the lytic activity of both recombinant and endogenous mouse TNF-alpha at low concentrations in vitro, and is effective in vivo.
  • TN3-19.12 is used to distinguish TNF-dependent mechanisms by comparing outcomes in treated versus untreated animals.
  • The antibody is also utilized in sandwich ELISA or ELISPOT assays for detection, but its principal in vivo application is for functional neutralization.

Summary Table: TN3-19.12 in Mouse Studies

FunctionApplication in MiceReference
Neutralizes TNF-alpha (and cross-reacts with TNF-beta)Blocks TNF activity to probe TNF function, dampen inflammation, test TNF-dependent pathologies
In vivo administrationPre-challenge or therapeutically during inflammation or immune activation (e.g., LPS model)
Functional controlDemonstrates TNF necessity by comparing with and without neutralization

Conclusion:
TN3-19.12 is an established tool for studying TNF biology in vivo by specifically and effectively neutralizing murine TNF activities, helping clarify the cytokine’s role in acute and chronic disease models.

The clone TN3-19.12 (Mouse TNF-alpha Antibody) has specific storage temperature requirements that depend on the duration and condition of storage.

Short-term Storage

For short-term storage after reconstitution, the antibody should be kept at 2 to 8°C under sterile conditions for up to 1 month. This refrigeration temperature maintains antibody stability and activity for immediate experimental use.

Long-term Storage

For longer-term storage after reconstitution, the antibody should be stored at -20 to -70°C under sterile conditions for up to 6 months. Some suppliers specifically recommend storage at ? -70°C for extended periods to maximize stability.

Initial Storage

As supplied in its sterile packaged form before reconstitution, the antibody maintains stability for 12 months when stored at -20 to -70°C.

Additional Storage Considerations

When storing this antibody, it's important to avoid repeated freeze-thaw cycles, which can compromise antibody integrity. For this reason, functional grade preclinical antibodies like clone TN3-19.12 should be aliquoted into working volumes without dilution before freezing. The antibody should be handled in a sterile environment and may require filtration through a 0.2 ?m filter for certain applications.

The storage temperature recommendations ensure that this hamster anti-mouse TNF-alpha monoclonal antibody retains its binding capacity and functional activity for research applications.

Antibodies and Proteins Commonly Used with TN3-19.12

The TN3-19.12 monoclonal antibody, which targets mouse and rat TNF-? (and cross-reacts with TNF-?/lymphotoxin), is widely used in immunology research. Its applications often involve pairing with other antibodies or proteins, especially in multiplex assays and functional experiments.

Related Antibodies

  • Biotinylated Poly5160 Antibody (BioLegend): Commonly used as the detecting antibody in sandwich ELISA or ELISPOT assays when TN3-19.12 serves as the capture antibody. This pairing enables specific, sensitive detection of mouse/rat TNF-? in complex samples.
  • Isotype Controls: For flow cytometry and intracellular cytokine staining, hamster IgG1, ? isotype controls (e.g., PE-G235-2356, BD Biosciences) are used alongside TN3-19.12 to assess background and specificity of staining.
  • Unconjugated TN3-19.12: Used as a blocking control in flow cytometry and intracellular cytokine staining protocols, demonstrating specificity by pre-blocking cells prior to staining with the conjugated version.
  • Polyvalent Rabbit Anti-rTNF: In some literature, polyvalent rabbit anti-rTNF has been used with TN3-19.12 to set up mouse TNF-specific ELISAs, sometimes for comparison or increased assay robustness.

Cell and Protein Preparations

  • Recombinant Mouse TNF-? (rMuTNF-?): Often used as a standard or inhibitory agent in functional neutralization assays.
  • Culture Supernatants from Activated T Cells: These supernatants, containing both TNF-? and TNF-? (lymphotoxin), are commonly analyzed to demonstrate the antibody's specificity and cross-reactivity.

Application-Specific Protocols

  • ELISA/ELISPOT: TN3-19.12 typically serves as the capture antibody, paired with a biotinylated or otherwise labeled secondary antibody for detection.
  • Flow Cytometry/Intracellular Staining: TN3-19.12 (PE-, APC-, or unconjugated) is used for identifying and enumerating TNF-producing cells, often in conjunction with isotype controls and blocking protocols.
  • Western Blot: While not routinely validated by all vendors, TN3-19.12 has been reported useful for detecting both TNF-? and TNF-? in cellular or recombinant protein preparations.
  • Neutralization Assays: TN3-19.12 is used alone or in combination with bioactivity standards (e.g., recombinant TNF) to neutralize TNF activity in vitro.

Summary Table

ApplicationCommonly Used Partner Antibodies/ProteinsNotes
ELISA/ELISPOTBiotinylated Poly5160, polyvalent rabbit anti-rTNFSandwich format; TN3-19.12 as capture, Poly5160 as detector
Flow CytometryHamster IgG1, ? isotype control, unconjugated TN3-19.12For specificity controls and background assessment
Western Blot/IPRecombinant TNF-?, TNF-? (LT)Detection of native and recombinant TNF forms
NeutralizationRecombinant TNF-?Functional in vitro bioactivity assays

Key Literature Points

  • Sheehan, K., et al. 1989: Demonstrated neutralization of murine TNF-? by TN3-19.12.
  • Merrick, B.A., et al. 1992 and Takahashi, S., et al. 1995: Examples of functional and assay applications in the literature.
  • Finkelman, F., et al. 2003: Protocol references for cytokine detection in Current Protocols in Immunology.

In summary, TN3-19.12 is most commonly paired with biotinylated or fluorescently labeled secondary antibodies (e.g., Poly5160) and relevant isotype controls in sandwich assays and flow cytometry. Recombinant TNF-? and activated T cell supernatants are frequently used as standards or inhibitory agents in functional studies.

The clone TN3-19.12 is a monoclonal antibody that has been widely used in scientific research, particularly for its ability to react with rat and mouse tumor necrosis factor-alpha (TNF-?) proteins. Here are some key findings from its citations in scientific literature:

  1. Neutralization of TNF-?: The TN3-19.12 antibody has been shown to effectively neutralize murine TNF-?, which suggests its potential use in therapeutic applications to reduce inflammation and disease severity.

  2. Cross-reactivity and Specificity: It also cross-reacts with mouse lymphotoxin-?1 (LT-?1), demonstrating its broad reactivity against related cytokines. Specificity studies have been conducted to ensure the antibody's binding is specific to TNF-?, such as blocking experiments with recombinant rat TNF.

  3. Experimental Autoimmune Encephalomyelitis (EAE) Model: In studies using the EAE model, treatment with TN3-19.12 reduced the severity of disease, indicating its potential in treating autoimmune diseases by inhibiting TNF-? activity.

  4. Flow Cytometry and Research Applications: The antibody is used in flow cytometry for staining TNF-producing cells, providing valuable insights into immune responses and cellular functions.

Overall, the TN3-19.12 antibody is a versatile tool for studying TNF-? and its role in various biological processes, as well as for potential therapeutic interventions in inflammatory diseases.

References & Citations

1.) El-Harith el-HA et al. (2004) Saudi Med J. 25: 135
2.) Adolf GR et al. (1990) Infec Immun. 58: 3996
3.) Kanneganti et al. (2020) bioRxiv 361048 Journal Link
4.) Fhogartaigh, C.N. et al. (2020) Nat Commun 11, 6385 Journal Link
5.) Karki et al. (2021) Cell. 184:149–168 Journal Link
6.) Karki, R. et al. (2021) Cell 184(1):149–168.e17 Journal Link
in vivo Protocol
Immunoprecipitation Protocol
N
General Western Blot Protocol

Certificate of Analysis

- -
- -

Formats Available

- -
- -
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.